Cite
HARVARD Citation
Blumenschein, G. et al. (2022). Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer. Journal for immunotherapy of cancer. 10 (1), p. . [Online].